We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

81 hedge funds and large institutions have $7.96M invested in Ampio Pharmaceuticals Inc. in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

976% more call options, than puts

Call options by funds: $226K | Put options by funds: $21K

6% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 16

4% less funds holding

Funds holding: 84 → 81 (-3)

28% less capital invested

Capital invested by funds: $11M → $7.96M (-$3.03M)

28% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 18

Holders
81
Holders Change
-3
Holders Change %
-3.57%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
13
Reduced
18
Closed
16
Calls
$226K
Puts
$21K
Net Calls
+$205K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$2.78M
2
Millennium Management
Millennium Management
New York
+$1M
3
Bank of America
Bank of America
North Carolina
+$280K
4
Goldman Sachs
Goldman Sachs
New York
+$235K
5
PP
Paloma Partners
Connecticut
+$233K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.5M
2
State Street
State Street
Massachusetts
-$547K
3
GCP
GSA Capital Partners
United Kingdom
-$314K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$195K
5
MA
Montag & Associates
Georgia
-$129K
Name Holding Trade Value Shares
Change 		Change in
Stake
OWP
51
Obermeyer Wealth Partners
Colorado
$8K – – –
JWM
52
Janiczek Wealth Management
Colorado
$6K – – –
Commonwealth Equity Services
53
Commonwealth Equity Services
Massachusetts
$6K +$2.85K +18 +53%
Wolverine Trading
54
Wolverine Trading
Illinois
$6K +$7.76K +49 New
SSA
55
Schonfeld Strategic Advisors
New York
$6K +$8.08K +51 New
Brown Advisory
56
Brown Advisory
Maryland
$6K +$8.87K +56 New
IWM
57
IHT Wealth Management
Illinois
$6K +$8.87K +56 New
BCM
58
Brookstone Capital Management
Illinois
$5K – – –
Legal & General Group
59
Legal & General Group
United Kingdom
$5K – – –
PNC Financial Services Group
60
PNC Financial Services Group
Pennsylvania
$5K – – –
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$4.74K -$7.13K -45 -52%
CAL
62
Capital Analysts LLC
Pennsylvania
$4K – – –
OC
63
Oppenheimer & Co
New York
$4K – – –
ProShare Advisors
64
ProShare Advisors
Maryland
$4K – – –
GWM
65
Geneos Wealth Management
Colorado
$3K -$2.54K -16 -33%
LTFS
66
Ladenburg Thalmann Financial Services
Florida
$3K – – –
Northwestern Mutual Wealth Management
67
Northwestern Mutual Wealth Management
Wisconsin
$3K – – –
WA
68
WealthTrust Axiom
Pennsylvania
$3K – – –
SCA
69
Stonebridge Capital Advisors
Minnesota
$2K +$2.69K +17 New
APA
70
American Portfolios Advisors
New York
$1.16K – – –
AF
71
Allworth Financial
California
$1K – – –
CFG
72
Citizens Financial Group
Rhode Island
$1K – – –
CTB
73
Country Trust Bank
Illinois
$1K – – –
CCM
74
Covington Capital Management
California
$1K – – –
MA
75
MUFG Americas
New York
$1K – – –
1 2
3
4

AMPE Hedge Fund Activity: Q2 2019 in Review

81 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2019, worth a combined $7.96M — down 28% from $11M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AMPE and 15 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 13 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.78M. The largest seller was BlackRock, cutting an estimated $2.5M.

  • 81 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2019, down from 84 in Q1 2019.
  • Funds reported $7.96M of Ampio Pharmaceuticals Inc. stock for Q2 2019, down 28% quarter-over-quarter.
  • 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2019 and 16 closed out, a net change of -1 holder.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2019 was Sabby Management, an estimated $2.78M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2019 was BlackRock, an estimated $2.5M sold.

Based on aggregated 13F filings for Q2 2019.